1. Home
  2. MXCT vs CANG Comparison

MXCT vs CANG Comparison

Compare MXCT & CANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

N/A

Current Price

$1.37

Market Cap

136.2M

Sector

Health Care

ML Signal

N/A

Logo Cango Inc.  each representing two (2)

CANG

Cango Inc. each representing two (2)

N/A

Current Price

$2.13

Market Cap

116.5M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MXCT
CANG
Founded
1999
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
136.2M
116.5M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
MXCT
CANG
Price
$1.37
$2.13
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$5.50
$3.00
AVG Volume (30 Days)
881.8K
309.7K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,026,000.00
N/A
Revenue This Year
N/A
$428.72
Revenue Next Year
$18.50
$18.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.17
52 Week High
$1.86
$5.55

Technical Indicators

Market Signals
Indicator
MXCT
CANG
Relative Strength Index (RSI) 61.04 67.51
Support Level $1.19 $1.22
Resistance Level $1.54 $2.36
Average True Range (ATR) 0.10 0.27
MACD 0.02 -0.02
Stochastic Oscillator 62.98 87.08

Price Performance

Historical Comparison
MXCT
CANG

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

About CANG Cango Inc. each representing two (2)

Cango Inc is a Bitcoin mining company with a vision to establish an integrated, world-wide infrastructure platform capable of powering the future digital economy. The operations are divided into two reportable segments (i) Bitcoin Mining Business and (ii) International Automobile Trading Business. The Company's mining operations span over 40 sites across North America, the Middle East, South America, and East Africa. Since entering the digital asset space in November 2024, Cango has activated pilot projects in both integrated energy solutions and distributed AI computing. In parallel, Cango continues to operate an online international used car export business through its subsidiary.

Share on Social Networks: